Nick Glover

Nick Glover is a seasoned executive in the biotechnology and pharmaceutical sectors, currently serving as the CEO of MycRx since 2020, focusing on oral, small molecule inhibitors for cancer treatment. Glover holds strategic advisory roles in various companies, including Phoenix Molecular Designs, Pattern Pharma, and PDX Pharmaceuticals, and contributes as a member of the Board of Directors for GLG and MEI Pharma. Glover's previous leadership experience includes roles as President and CEO of Sierra Oncology and YM BioSciences, where significant advancements in cancer therapies were achieved. Glover holds a Ph.D. in Chemistry from Simon Fraser University and has extensive expertise in drug discovery, pharmaceutical development, and corporate strategy.